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The present study shows the potential of novel nanovectors for the delivery of
lipophilic radionuclides and therapeutic molecules to the brain. Lipid nanocapsules
(LNC) inhibiting the P-gp pump efflux, were conjugated to OX26 monoclonal
antibodies (OX26 MAb) and Fab' fragments. The OX26 MAb is directed against the
transferrin receptor (TfR) highly expressed on the cerebral endothelium. The
specific association of immunonanocapsules to rat brain capillary endothelial cells
was demonstrated. Biodistribution of immunonanocapsules, labeled with a (188)Re
lipophilic complex, was determined in healthy rats. At 24 h post-injection, the brain
concentrations of Fab'-immunonanocapsules and OX26-immunonanocapsules were,
respectively, 1.5 and 2-fold higher than non-targeted nanocapsules. In addition,
Fab' fragments helped prolong the vascular residence time of the nanovectors but
their affinity to TfR was lower than whole antibodies. The ability of
immunonanocapsules to specifically target cerebral tissues in addition to the
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